Don't Just Read the News, Understand It.
Published loading...Updated

Acadia’s ‘Very Bullish’ Sales Forecast Restores some Confidence on Wall Street

Summary by biopharmadive.com
The brain drug developer is now saying that its two marketed products could ultimately bring in $2 billion annually, and its pipeline may one day add another $12 billion in sales each year.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

biopharmadive.com broke the news in on Thursday, June 26, 2025.
Sources are mostly out of (0)